Founded in 2001 as Tsunami Research, Appistry is bringing the power of genomics to next-generation medicine by making genomics data easier for researchers and clinicians to act on. Appistry CloudDx provides cost-effective access to established, laboratory developed tests so that clinically relevant genomics-based information can be usable by any physician, anywhere. Appistry also empowers researchers by providing world-class bioinformatics tools, cloud services, and software that streamline the analysis of next-generation sequencing data and provide easy scale for moving research-developed pipelines into production. In 2012, the Broad Institute selected Appistry as its authorized software commercialization partner, and in this role Appistry has provided several suites of tools that make these powerful tools for NGS analysis easier to implement and use.
